Bristol-Myers Squibb Executive and Leadership Team

Benjamin Kingscott, the Manager, Chief Technology Officer Plant Engineering at Bristol-Myers Squibb, directs the technical infrastructure supporting large-scale pharmaceutical manufacturing. Kingscott oversees the integration of advanced engineering systems to ensure facility compliance and operational efficiency across global production sites. By optimizing plant utility and equipment reliability, the Manager, Chief Technology Officer Plant Engineering maintains the high standards required for complex medication synthesis. Benjamin Kingscott coordinates with cross-functional teams to implement sustainable manufacturing technologies that reduce environmental impact while increasing output capacity. This leadership role involves managing capital projects that modernize production lines to meet evolving regulatory requirements. Through meticulous oversight of facility maintenance and technical upgrades, Kingscott ensures that manufacturing capabilities align with the broader organizational goal of delivering high-quality therapeutic solutions to patients worldwide. The Manager, Chief Technology Officer Plant Engineering drives continuous improvement initiatives that enhance the overall agility of the company's manufacturing network.

Kimberly Kam, the Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II at Bristol-Myers Squibb, architects the validation protocols necessary for bringing new biopharmaceutical products to market. Kam manages the technical assessment of manufacturing processes to guarantee consistency and safety in drug production. By executing rigorous validation studies, the Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II ensures that every stage of the development lifecycle meets stringent quality benchmarks. Kimberly Kam collaborates with research and development teams to translate scientific breakthroughs into scalable, reliable manufacturing workflows. This role involves analyzing process data to identify potential risks and implementing mitigation strategies that safeguard product integrity. Through the application of advanced analytical techniques, Kam supports the company's mission to address serious patient needs with precision-engineered medications. The Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II maintains operational excellence by ensuring that all validation activities adhere to global regulatory standards.

Hena Abidi, the S & O Lead For Rdc People Organization Chief of Staff at Bristol-Myers Squibb, directs the strategic alignment of human capital initiatives within the research and development centers. Abidi manages organizational design and talent development programs that foster a culture of scientific innovation. By coordinating cross-departmental workflows, the S & O Lead For Rdc People Organization Chief of Staff ensures that personnel resources support the company's ambitious drug discovery pipeline. Hena Abidi facilitates communication between leadership teams to streamline decision-making processes and enhance operational efficiency. This role involves analyzing organizational performance metrics to drive improvements in workforce engagement and productivity. Through the implementation of strategic talent strategies, Abidi supports the organization's ability to attract and retain top-tier scientific talent. The S & O Lead For Rdc People Organization Chief of Staff maintains a focus on building a resilient, high-performing culture that translates complex research goals into tangible therapeutic advancements for patients across the globe.

Scott Trautwein, the Manager, Chief Technology Officer MSAT Process Validation at Bristol-Myers Squibb, oversees the technical validation of manufacturing processes for the company's diverse medication portfolio. Trautwein directs the development of robust testing frameworks that verify the efficacy and safety of pharmaceutical products during the transition from clinical trials to commercial production. By managing the technical lifecycle of manufacturing processes, the Manager, Chief Technology Officer MSAT Process Validation ensures that production systems remain compliant with international quality standards. Scott Trautwein collaborates with engineering and quality assurance teams to resolve technical challenges and optimize process performance. This leadership role involves implementing data-driven methodologies to enhance the reliability of drug manufacturing operations. Through the rigorous application of process validation principles, Trautwein supports the company's commitment to delivering consistent, high-quality treatments for complex conditions. The Manager, Chief Technology Officer MSAT Process Validation drives operational stability by ensuring that all manufacturing workflows meet the highest levels of technical precision.

Imara Charles, the Vice President, Chief of Staff, Global Product Development and Supply at Bristol-Myers Squibb, directs the strategic integration of product development and global supply chain operations. Charles manages the coordination of cross-functional teams to ensure the seamless delivery of medications from the laboratory to the patient. By overseeing the alignment of supply chain logistics with product development timelines, the Vice President, Chief of Staff, Global Product Development and Supply optimizes the company's ability to respond to market demands. Imara Charles facilitates high-level decision-making processes that balance research innovation with manufacturing scalability. This role involves managing strategic partnerships and operational initiatives that enhance the efficiency of the global supply network. Through the oversight of complex product development cycles, Charles ensures that the organization maintains a consistent supply of life-saving therapies. The Vice President, Chief of Staff, Global Product Development and Supply drives operational excellence by fostering collaboration across the entire product lifecycle.

Divya Sahdev, the Senior Director, Governance and Portfolio Operations, GPS Chief of Staff at Bristol-Myers Squibb, directs the governance frameworks that oversee the company's global product supply portfolio. Sahdev manages the strategic prioritization of operational projects to ensure alignment with the organization's long-term therapeutic goals. By implementing rigorous oversight mechanisms, the Senior Director, Governance and Portfolio Operations, GPS Chief of Staff maintains transparency and accountability across all supply chain functions. Divya Sahdev coordinates with executive leadership to evaluate portfolio performance and allocate resources effectively. This role involves designing operational policies that streamline decision-making and mitigate risks within the global supply network. Through the management of portfolio operations, Sahdev supports the company's ability to deliver innovative treatments to patients in diverse markets. The Senior Director, Governance and Portfolio Operations, GPS Chief of Staff drives organizational efficiency by ensuring that governance structures support the rapid development and distribution of essential pharmaceutical products.

Debra Golding, the Senior Executive Associate, Chief of Staff and Compliance at Bristol-Myers Squibb, directs the administrative and compliance functions that support executive leadership. Golding manages the integration of regulatory requirements into daily operational workflows to ensure adherence to industry standards. By overseeing the flow of information and strategic priorities, the Senior Executive Associate, Chief of Staff and Compliance facilitates effective communication across the leadership team. Debra Golding coordinates compliance audits and policy development to safeguard the organization's reputation and operational integrity. This role involves managing complex administrative projects that enhance the efficiency of executive decision-making. Through the rigorous application of compliance protocols, Golding supports the company's commitment to ethical business practices and patient safety. The Senior Executive Associate, Chief of Staff and Compliance drives organizational stability by ensuring that all leadership activities remain aligned with the company's core values and regulatory obligations in the global biopharmaceutical market.

Yograj Jadav, the Manager, Chief Technology Officer MSAT Process Validation (CAR- T) at Bristol-Myers Squibb, directs the technical validation of complex cell therapy manufacturing processes. Jadav manages the development of specialized protocols required for the production of CAR-T immunotherapies, ensuring that these advanced treatments meet rigorous safety and efficacy standards. By overseeing the technical aspects of cell therapy validation, the Manager, Chief Technology Officer MSAT Process Validation (CAR- T) supports the company's leadership in oncology innovation. Yograj Jadav collaborates with research teams to refine manufacturing workflows that enable the scalable production of personalized patient treatments. This role involves analyzing process data to ensure consistency in the highly sensitive environment of cell therapy manufacturing. Through the application of advanced technical expertise, Jadav ensures that the company's CAR-T portfolio remains at the forefront of medical science. The Manager, Chief Technology Officer MSAT Process Validation (CAR- T) drives operational success by maintaining the highest quality standards for life-saving immunotherapies.

Joshua Sugrim, the Manager, Chief Technology Officer MSAT Process Validation - CAR T Cell Therapy at Bristol-Myers Squibb, architects the technical validation strategies for the company's expanding CAR-T cell therapy platform. Sugrim manages the implementation of process controls that ensure the reliability and quality of these innovative cancer treatments. By directing the validation of complex manufacturing steps, the Manager, Chief Technology Officer MSAT Process Validation - CAR T Cell Therapy supports the successful delivery of personalized therapies to patients. Joshua Sugrim coordinates with cross-functional teams to troubleshoot technical issues and optimize the performance of cell therapy production lines. This role involves managing the technical documentation and regulatory filings necessary for the commercialization of new cell-based products. Through the application of rigorous validation methodologies, Sugrim ensures that the company's manufacturing capabilities meet the unique demands of cell therapy. The Manager, Chief Technology Officer MSAT Process Validation - CAR T Cell Therapy drives innovation by maintaining technical excellence in the production of advanced oncology solutions.

John Van Oostendorp, the Manager, Chief Technology Officer Site Supply Chain Compliance at Bristol-Myers Squibb, directs the compliance frameworks governing the company's global supply chain operations. Van Oostendorp manages the implementation of quality and regulatory standards across all manufacturing sites to ensure the integrity of the medication supply. By overseeing supply chain compliance, the Manager, Chief Technology Officer Site Supply Chain Compliance mitigates operational risks and ensures that all distribution activities adhere to international pharmaceutical regulations. John Van Oostendorp coordinates with site leadership to monitor performance metrics and implement corrective actions when necessary. This role involves managing the technical aspects of supply chain audits and ensuring that all logistics processes support the company's commitment to patient access. Through the rigorous application of compliance protocols, Van Oostendorp supports the stability of the global supply network. The Manager, Chief Technology Officer Site Supply Chain Compliance drives operational reliability by ensuring that every link in the supply chain meets the highest quality standards.